UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microgel organocatalysts: modulation of reaction rates at liquid-liquid interfaces

Materials advances, 2020-11, Vol.1 (8), p.2983-2993

2020

Volltextzugriff (PDF)

Epstein Barr Virus-Associated Primary CNS Lymphomas in Elderly Patients on Immunosuppressive Medications

Journal of neuropathology and experimental neurology, 2008-11, Vol.67 (11), p.1103-1111

2008

Volltextzugriff (PDF)

Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.1066-1074

2011

Volltextzugriff (PDF)

Favorable Prognosis in Patients With High-Grade Glioma With Radiation Necrosis: The University of Colorado Reoperation Series

International journal of radiation oncology, biology, physics, 2011-09, Vol.81 (1), p.211-217

2011

Volltextzugriff (PDF)

Rgnef promotes ovarian tumor progression and confers protection from oxidative stress

Oncogene, 2019-09, Vol.38 (36), p.6323-6337

2019

Volltextzugriff (PDF)

Lymphomatosis cerebri as a cause of white matter dementia

Human pathology, 2005-03, Vol.36 (3), p.282-290

2005

Volltextzugriff (PDF)

Anaplastic PXA in adults: case series with clinicopathologic and molecular features

Journal of neuro-oncology, 2013-01, Vol.111 (1), p.59-69

2013

Volltextzugriff (PDF)

NTOX-11. RECURRENT EPISODES OF STROKE-LIKE MIGRAINE ATTACKS AFTER RADIATION THERAPY (SMART) SYNDROME IN ADULTS

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi143-vi143

2016

Volltextzugriff (PDF)

A time-resolved proteomic and prognostic map of COVID-19

Cell systems, 2021-08, Vol.12 (8), p.780-794.e7

2021

Volltextzugriff (PDF)

Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma

Journal of neuro-oncology, 2015-03, Vol.122 (1), p.135-143

2015

Volltextzugriff (PDF)

Muscle adaptations in acute SCI following overground exoskeleton + FES training: A pilot study

Frontiers in rehabilitation sciences, 2022-10, Vol.3, p.963771-963771

2022

Volltextzugriff (PDF)

The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis

Journal of neuro-oncology, 2010-02, Vol.96 (3), p.375-384

2010

Volltextzugriff (PDF)

Abstract TMEM-027: TARGETING RGNEF (P190RHOGEF/ARHGEF28) IMPAIRS OVARIAN TUMOR INITIATION AND PROGRESSION

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.TMEM-027-TMEM-027

2017

Volltextzugriff (PDF)

PATH-48. FUSION TESTING IN ADULT VERSUS PEDIATRIC LOW AND HIGH GRADE BRAIN TUMORS FOR ELIGIBILITY FOR TRIALS

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi169-vi169

2018

Volltextzugriff (PDF)

Genetic characterization of gliomas arising in patients with multiple sclerosis

Journal of neuro-oncology, 2012-09, Vol.109 (2), p.261-272

2012

Volltextzugriff (PDF)

Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors

Journal of cataract and refractive surgery, 2007-06, Vol.33 (6), p.978-988

ESCRS Endophthalmitis Study Group

2007

Volltextzugriff (PDF)

Abstract A61: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Clinical cancer research, 2020-07, Vol.26 (13_Supplement), p.A61-A61

2020

Volltextzugriff (PDF)

Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients

Hepatology international, 2023-12, Vol.17 (6), p.1610-1625

2023

Volltextzugriff (PDF)

Abstract 1991: Vulnerability of platinum-resistant ovarian cancer to FAK inhibition

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1991-1991

2018

Volltextzugriff (PDF)

Abstract 3157: An Rgnef (p190RhoGEF/Arhgef28) signaling axis regulates ovarian cancer progression

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3157-3157

2014

Volltextzugriff (PDF)

RT-24 EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV)

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v192-v192

2014

Volltextzugriff (PDF)

RT-24EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV)

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v192-v192

2014

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Microgel organocatalysts: modulation of reaction rates at liquid-liquid interfaces

Epstein Barr Virus-Associated Primary CNS Lymphomas in Elderly Patients on Immunosuppressive Medications

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Favorable Prognosis in Patients With High-Grade Glioma With Radiation Necrosis: The University of Colorado Reoperation Series

Rgnef promotes ovarian tumor progression and confers protection from oxidative stress

Lymphomatosis cerebri as a cause of white matter dementia

Anaplastic PXA in adults: case series with clinicopathologic and molecular features

NTOX-11. RECURRENT EPISODES OF STROKE-LIKE MIGRAINE ATTACKS AFTER RADIATION THERAPY (SMART) SYNDROME IN ADULTS

A time-resolved proteomic and prognostic map of COVID-19

Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma

Muscle adaptations in acute SCI following overground exoskeleton + FES training: A pilot study

The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis

Abstract TMEM-027: TARGETING RGNEF (P190RHOGEF/ARHGEF28) IMPAIRS OVARIAN TUMOR INITIATION AND PROGRESSION

PATH-48. FUSION TESTING IN ADULT VERSUS PEDIATRIC LOW AND HIGH GRADE BRAIN TUMORS FOR ELIGIBILITY FOR TRIALS

Genetic characterization of gliomas arising in patients with multiple sclerosis

Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study

Abstract A61: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections: an observational study

Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients

Abstract 1991: Vulnerability of platinum-resistant ovarian cancer to FAK inhibition

Abstract 3157: An Rgnef (p190RhoGEF/Arhgef28) signaling axis regulates ovarian cancer progression

RT-24 EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV)

RT-24EXTENT OF CEREBRAL RADIONECROSIS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED ON A CLINICAL TRIAL WITH HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (HYPO-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV)

Aktive Filter

Suchergebnisse filtern